Listed

Biogen Inc.

BIIBNasdaqCIK 875045HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$2.80bn, Q3 FY2026
Net income−$20.6m, Q3 FY2026
Biogen Inc., income statement, quarterly
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Revenue$m2,386Revenue, Q4 FY2023, three months to 2023-12-31$2.39bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure2,291Revenue, Q1 FY2024, three months to 2024-03-31$2.29bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-01, accession 0000875045-25-000018.Report this figure2,465Revenue, Q2 FY2024, three months to 2024-06-30$2.46bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-07-31, accession 0000875045-25-000033.Report this figure2,466Revenue, Q3 FY2024, three months to 2024-09-30$2.47bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-30, accession 0000875045-25-000049.Report this figure2,455Revenue, Q4 FY2024, three months to 2024-12-31$2.45bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure2,431Revenue, Q1 FY2025, three months to 2025-03-31$2.43bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure2,646Revenue, Q2 FY2025, three months to 2025-06-30$2.65bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure2,535Revenue, Q3 FY2025, three months to 2025-09-30$2.53bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure2,279Revenue, Q4 FY2025, three months to 2025-12-31$2.28bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure2,478Revenue, Q1 FY2026, three months to 2026-03-31$2.48bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure2,736Revenue, Q2 FY2026, three months to 2026-06-30$2.74bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure2,804Revenue, Q3 FY2026, three months to 2026-09-30$2.80bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure
Cost of revenue$m618Cost of revenue, Q4 FY2023, three months to 2023-12-31$618.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure542Cost of revenue, Q1 FY2024, three months to 2024-03-31$542.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-01, accession 0000875045-25-000018.Report this figure546Cost of revenue, Q2 FY2024, three months to 2024-06-30$546.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-07-31, accession 0000875045-25-000033.Report this figure639Cost of revenue, Q3 FY2024, three months to 2024-09-30$638.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-30, accession 0000875045-25-000049.Report this figure584Cost of revenue, Q4 FY2024, three months to 2024-12-31$583.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure629Cost of revenue, Q1 FY2025, three months to 2025-03-31$629.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure605Cost of revenue, Q2 FY2025, three months to 2025-06-30$605.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure674Cost of revenue, Q3 FY2025, three months to 2025-09-30$674.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure496Cost of revenue, Q4 FY2025, three months to 2025-12-31$495.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure661Cost of revenue, Q1 FY2026, three months to 2026-03-31$661.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure777Cost of revenue, Q2 FY2026, three months to 2026-06-30$776.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure748Cost of revenue, Q3 FY2026, three months to 2026-09-30$748.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure
Gross profit$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Selling, general and administrative$m609Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$608.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure582Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$581.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-01, accession 0000875045-25-000018.Report this figure554Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$553.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-07-31, accession 0000875045-25-000033.Report this figure588Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$588.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-30, accession 0000875045-25-000049.Report this figure680Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$680.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure573Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$572.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure584Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$583.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure595Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$594.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure683Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$682.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure607Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$607.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure710Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$709.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure752Selling, general and administrative, Q3 FY2026, three months to 2026-09-30$752.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure
Operating income$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Interest expense$m71.5Interest expense, Q4 FY2023, three months to 2023-12-31$71.5m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure69.2Interest expense, Q1 FY2024, three months to 2024-03-31$69.2m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-01, accession 0000875045-25-000018.Report this figure61.3Interest expense, Q2 FY2024, three months to 2024-06-30$61.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-07-31, accession 0000875045-25-000033.Report this figure59.8Interest expense, Q3 FY2024, three months to 2024-09-30$59.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-10-30, accession 0000875045-25-000049.Report this figure60.0Interest expense, Q4 FY2024, three months to 2024-12-31$60.0m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure60.0Interest expense, Q1 FY2025, three months to 2025-03-31$60.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure72.6Interest expense, Q2 FY2025, three months to 2025-06-30$72.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure67.4Interest expense, Q3 FY2025, three months to 2025-09-30$67.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure67.5Interest expense, Q4 FY2025, three months to 2025-12-31$67.5m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure67.6Interest expense, Q1 FY2026, three months to 2026-03-31$67.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure82.3Interest expense, Q2 FY2026, three months to 2026-06-30$82.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure87.5Interest expense, Q3 FY2026, three months to 2026-09-30$87.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure
Income tax$m42.7Income tax, Q4 FY2023, three months to 2023-12-31$42.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure71.4Income tax, Q1 FY2024, three months to 2024-03-31$71.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-01, accession 0000875045-25-000018.Report this figure115Income tax, Q2 FY2024, three months to 2024-06-30$115.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-31, accession 0000875045-25-000033.Report this figure62.5Income tax, Q3 FY2024, three months to 2024-09-30$62.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-30, accession 0000875045-25-000049.Report this figure24.8Income tax, Q4 FY2024, three months to 2024-12-31$24.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure70.7Income tax, Q1 FY2025, three months to 2025-03-31$70.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure109Income tax, Q2 FY2025, three months to 2025-06-30$109.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure90.8Income tax, Q3 FY2025, three months to 2025-09-30$90.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure(7.1)Income tax, Q4 FY2025, three months to 2025-12-31−$7.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure58.2Income tax, Q1 FY2026, three months to 2026-03-31$58.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure34.9Income tax, Q2 FY2026, three months to 2026-06-30$34.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure11.6Income tax, Q3 FY2026, three months to 2026-09-30$11.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure
Net income$m250Net income, Q4 FY2023, three months to 2023-12-31$249.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure393Net income, Q1 FY2024, three months to 2024-03-31$393.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-01, accession 0000875045-25-000018.Report this figure584Net income, Q2 FY2024, three months to 2024-06-30$583.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-07-31, accession 0000875045-25-000033.Report this figure389Net income, Q3 FY2024, three months to 2024-09-30$388.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0000875045-25-000049.Report this figure267Net income, Q4 FY2024, three months to 2024-12-31$266.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure241Net income, Q1 FY2025, three months to 2025-03-31$240.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure635Net income, Q2 FY2025, three months to 2025-06-30$634.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure467Net income, Q3 FY2025, three months to 2025-09-30$466.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure(48.9)Net income, Q4 FY2025, three months to 2025-12-31−$48.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure320Net income, Q1 FY2026, three months to 2026-03-31$319.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure97.5Net income, Q2 FY2026, three months to 2026-06-30$97.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure(20.6)Net income, Q3 FY2026, three months to 2026-09-30−$20.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure
Diluted EPS$ per sharenot reported2.70Diluted EPS, Q1 FY2024, three months to 2024-03-31$2.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-01, accession 0000875045-25-000018.Report this figure4.00Diluted EPS, Q2 FY2024, three months to 2024-06-30$4.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-31, accession 0000875045-25-000033.Report this figure2.66Diluted EPS, Q3 FY2024, three months to 2024-09-30$2.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0000875045-25-000049.Report this figurenot reported1.64Diluted EPS, Q1 FY2025, three months to 2025-03-31$1.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure4.33Diluted EPS, Q2 FY2025, three months to 2025-06-30$4.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure3.17Diluted EPS, Q3 FY2025, three months to 2025-09-30$3.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figurenot reported2.15Diluted EPS, Q1 FY2026, three months to 2026-03-31$2.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure0.66Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure(0.14)Diluted EPS, Q3 FY2026, three months to 2026-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure
Basic EPS$ per sharenot reported2.71Basic EPS, Q1 FY2024, three months to 2024-03-31$2.71 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-01, accession 0000875045-25-000018.Report this figure4.01Basic EPS, Q2 FY2024, three months to 2024-06-30$4.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-31, accession 0000875045-25-000033.Report this figure2.67Basic EPS, Q3 FY2024, three months to 2024-09-30$2.67 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0000875045-25-000049.Report this figurenot reported1.65Basic EPS, Q1 FY2025, three months to 2025-03-31$1.65 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure4.33Basic EPS, Q2 FY2025, three months to 2025-06-30$4.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure3.18Basic EPS, Q3 FY2025, three months to 2025-09-30$3.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figurenot reported2.17Basic EPS, Q1 FY2026, three months to 2026-03-31$2.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure0.66Basic EPS, Q2 FY2026, three months to 2026-06-30$0.66 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure(0.14)Basic EPS, Q3 FY2026, three months to 2026-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure

Balance sheet

Long-term debt$7.29bn, Q3 FY2026
Shareholders' equity$18.92bn, Q3 FY2026
Biogen Inc., balance sheet, quarterly
Line itemUnitFY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Cash and equivalents$bnnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current assets$bn6.9Current assets, FY2023, at 2023-12-31$6.86bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-12, accession 0000875045-25-000009.Report this figure6.8Current assets, Q1 FY2024, at 2024-03-31$6.76bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-04-24, accession 0000875045-24-000016.Report this figure7.1Current assets, Q2 FY2024, at 2024-06-30$7.11bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-01, accession 0000875045-24-000025.Report this figure6.8Current assets, Q3 FY2024, at 2024-09-30$6.83bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-30, accession 0000875045-24-000032.Report this figure7.5Current assets, FY2024, at 2024-12-31$7.46bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-06, accession 0000875045-26-000013.Report this figure7.6Current assets, Q1 FY2025, at 2025-03-31$7.63bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-01, accession 0000875045-25-000018.Report this figure8.0Current assets, Q2 FY2025, at 2025-06-30$7.97bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-31, accession 0000875045-25-000033.Report this figure8.9Current assets, Q3 FY2025, at 2025-09-30$8.94bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-30, accession 0000875045-25-000049.Report this figure9.0Current assets, FY2025, at 2025-12-31$8.97bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure9.2Current assets, Q1 FY2026, at 2026-03-31$9.19bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure7.3Current assets, Q2 FY2026, at 2026-06-30$7.31bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure7.6Current assets, Q3 FY2026, at 2026-09-30$7.58bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure
Total assets$bn26.8Total assets, FY2023, at 2023-12-31$26.84bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-12, accession 0000875045-25-000009.Report this figure26.6Total assets, Q1 FY2024, at 2024-03-31$26.57bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-04-24, accession 0000875045-24-000016.Report this figure26.8Total assets, Q2 FY2024, at 2024-06-30$26.80bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-01, accession 0000875045-24-000025.Report this figure28.3Total assets, Q3 FY2024, at 2024-09-30$28.31bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-30, accession 0000875045-24-000032.Report this figure28.0Total assets, FY2024, at 2024-12-31$28.05bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-06, accession 0000875045-26-000013.Report this figure28.0Total assets, Q1 FY2025, at 2025-03-31$28.03bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-01, accession 0000875045-25-000018.Report this figure28.3Total assets, Q2 FY2025, at 2025-06-30$28.33bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-31, accession 0000875045-25-000033.Report this figure29.2Total assets, Q3 FY2025, at 2025-09-30$29.21bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-30, accession 0000875045-25-000049.Report this figure29.4Total assets, FY2025, at 2025-12-31$29.44bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure29.5Total assets, Q1 FY2026, at 2026-03-31$29.48bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure32.1Total assets, Q2 FY2026, at 2026-06-30$32.09bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure32.1Total assets, Q3 FY2026, at 2026-09-30$32.05bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure
Current liabilities$bn3.4Current liabilities, FY2023, at 2023-12-31$3.43bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-12, accession 0000875045-25-000009.Report this figure3.2Current liabilities, Q1 FY2024, at 2024-03-31$3.22bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-04-24, accession 0000875045-24-000016.Report this figure3.1Current liabilities, Q2 FY2024, at 2024-06-30$3.11bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-01, accession 0000875045-24-000025.Report this figure5.4Current liabilities, Q3 FY2024, at 2024-09-30$5.42bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-30, accession 0000875045-24-000032.Report this figure5.5Current liabilities, FY2024, at 2024-12-31$5.53bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-06, accession 0000875045-26-000013.Report this figure5.3Current liabilities, Q1 FY2025, at 2025-03-31$5.30bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-01, accession 0000875045-25-000018.Report this figure3.2Current liabilities, Q2 FY2025, at 2025-06-30$3.18bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-31, accession 0000875045-25-000033.Report this figure3.3Current liabilities, Q3 FY2025, at 2025-09-30$3.29bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-30, accession 0000875045-25-000049.Report this figure3.3Current liabilities, FY2025, at 2025-12-31$3.35bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure3.0Current liabilities, Q1 FY2026, at 2026-03-31$3.00bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure3.9Current liabilities, Q2 FY2026, at 2026-06-30$3.92bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure3.9Current liabilities, Q3 FY2026, at 2026-09-30$3.90bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure
Total liabilities$bn12.0Total liabilities, FY2023, at 2023-12-31$12.05bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-12, accession 0000875045-25-000009.Report this figure11.4Total liabilities, Q1 FY2024, at 2024-03-31$11.35bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-04-24, accession 0000875045-24-000016.Report this figure10.9Total liabilities, Q2 FY2024, at 2024-06-30$10.91bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-01, accession 0000875045-24-000025.Report this figure12.0Total liabilities, Q3 FY2024, at 2024-09-30$11.95bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-30, accession 0000875045-24-000032.Report this figure11.3Total liabilities, FY2024, at 2024-12-31$11.33bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-06, accession 0000875045-26-000013.Report this figure11.1Total liabilities, Q1 FY2025, at 2025-03-31$11.05bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-01, accession 0000875045-25-000018.Report this figure10.7Total liabilities, Q2 FY2025, at 2025-06-30$10.70bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-31, accession 0000875045-25-000033.Report this figure11.0Total liabilities, Q3 FY2025, at 2025-09-30$11.00bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-30, accession 0000875045-25-000049.Report this figure11.2Total liabilities, FY2025, at 2025-12-31$11.18bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure10.8Total liabilities, Q1 FY2026, at 2026-03-31$10.83bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure13.2Total liabilities, Q2 FY2026, at 2026-06-30$13.24bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure13.1Total liabilities, Q3 FY2026, at 2026-09-30$13.13bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure
Long-term debt$bn6.8Long-term debt, FY2023, at 2023-12-31$6.79bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-10-30, accession 0000875045-24-000032.Report this figure6.3Long-term debt, Q1 FY2024, at 2024-03-31$6.29bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-04-24, accession 0000875045-24-000016.Report this figure6.3Long-term debt, Q2 FY2024, at 2024-06-30$6.29bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-08-01, accession 0000875045-24-000025.Report this figure4.5Long-term debt, Q3 FY2024, at 2024-09-30$4.55bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-10-30, accession 0000875045-24-000032.Report this figure4.5Long-term debt, FY2024, at 2024-12-31$4.55bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-10-30, accession 0000875045-25-000049.Report this figure4.5Long-term debt, Q1 FY2025, at 2025-03-31$4.55bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-05-01, accession 0000875045-25-000018.Report this figure6.3Long-term debt, Q2 FY2025, at 2025-06-30$6.28bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-07-31, accession 0000875045-25-000033.Report this figure6.3Long-term debt, Q3 FY2025, at 2025-09-30$6.29bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-10-30, accession 0000875045-25-000049.Report this figure6.3Long-term debt, FY2025, at 2025-12-31$6.29bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure6.3Long-term debt, Q1 FY2026, at 2026-03-31$6.29bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure7.3Long-term debt, Q2 FY2026, at 2026-06-30$7.29bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure7.3Long-term debt, Q3 FY2026, at 2026-09-30$7.29bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure
Current portion of debt$bn0.2Current portion of debt, FY2023, at 2023-12-31$150.0m. XBRL concept us-gaap:DebtCurrent. 10-K filed 2025-02-12, accession 0000875045-25-000009.Report this figurenot reportednot reportednot reported1.7Current portion of debt, FY2024, at 2024-12-31$1.75bn. XBRL concept us-gaap:DebtCurrent. 10-K filed 2026-02-06, accession 0000875045-26-000013.Report this figurenot reportednot reportednot reported0.0Current portion of debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:DebtCurrent. 10-K filed 2026-02-06, accession 0000875045-26-000013.Report this figurenot reportednot reportednot reported
Shareholders' equity$bn14.8Shareholders' equity, FY2023, at 2023-12-31$14.80bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2024-02-14, accession 0000875045-24-000009.Report this figure15.2Shareholders' equity, Q1 FY2024, at 2024-03-31$15.21bn. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-07-31, accession 0000875045-25-000033.Report this figure15.9Shareholders' equity, Q2 FY2024, at 2024-06-30$15.89bn. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-10-30, accession 0000875045-25-000049.Report this figure16.4Shareholders' equity, Q3 FY2024, at 2024-09-30$16.36bn. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-10-30, accession 0000875045-25-000049.Report this figure16.7Shareholders' equity, FY2024, at 2024-12-31$16.72bn. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure17.0Shareholders' equity, Q1 FY2025, at 2025-03-31$16.98bn. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure17.6Shareholders' equity, Q2 FY2025, at 2025-06-30$17.63bn. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure18.2Shareholders' equity, Q3 FY2025, at 2025-09-30$18.21bn. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure18.3Shareholders' equity, FY2025, at 2025-12-31$18.26bn. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure18.7Shareholders' equity, Q1 FY2026, at 2026-03-31$18.65bn. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure18.8Shareholders' equity, Q2 FY2026, at 2026-06-30$18.85bn. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure18.9Shareholders' equity, Q3 FY2026, at 2026-09-30$18.92bn. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure

Cash flow

Operating cash flow$640.8m, Q3 FY2026
Capital expenditure$40.4m, Q3 FY2026
Share repurchases$0, Q4 FY2023
Biogen Inc., cash flow, quarterly
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Operating cash flow$m12.5Operating cash flow, Q4 FY2023, three months to 2023-12-31$12.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure553Operating cash flow, Q1 FY2024, three months to 2024-03-31$553.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-01, accession 0000875045-25-000018.Report this figure626Operating cash flow, Q2 FY2024, three months to 2024-06-30$625.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-31, accession 0000875045-25-000033. Derived: 6-month figure less the 3-month figure.Report this figure936Operating cash flow, Q3 FY2024, three months to 2024-09-30$935.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0000875045-25-000049. Derived: 9-month figure less the 6-month figure.Report this figure761Operating cash flow, Q4 FY2024, three months to 2024-12-31$760.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure259Operating cash flow, Q1 FY2025, three months to 2025-03-31$259.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure161Operating cash flow, Q2 FY2025, three months to 2025-06-30$160.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0000875045-26-000075. Derived: 6-month figure less the 3-month figure.Report this figure1,273Operating cash flow, Q3 FY2025, three months to 2025-09-30$1.27bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-28, accession 0000875045-26-000096. Derived: 9-month figure less the 6-month figure.Report this figure512Operating cash flow, Q4 FY2025, three months to 2025-12-31$511.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure646Operating cash flow, Q1 FY2026, three months to 2026-03-31$645.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure449Operating cash flow, Q2 FY2026, three months to 2026-06-30$448.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0000875045-26-000075. Derived: 6-month figure less the 3-month figure.Report this figure641Operating cash flow, Q3 FY2026, three months to 2026-09-30$640.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-28, accession 0000875045-26-000096. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$m65.2Capital expenditure, Q4 FY2023, three months to 2023-12-31$65.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure45.9Capital expenditure, Q1 FY2024, three months to 2024-03-31$45.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-01, accession 0000875045-25-000018.Report this figure33.5Capital expenditure, Q2 FY2024, three months to 2024-06-30$33.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-31, accession 0000875045-25-000033. Derived: 6-month figure less the 3-month figure.Report this figure35.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$35.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0000875045-25-000049. Derived: 9-month figure less the 6-month figure.Report this figure39.3Capital expenditure, Q4 FY2024, three months to 2024-12-31$39.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure37.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$37.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure26.6Capital expenditure, Q2 FY2025, three months to 2025-06-30$26.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-29, accession 0000875045-26-000075. Derived: 6-month figure less the 3-month figure.Report this figure46.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$46.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-28, accession 0000875045-26-000096. Derived: 9-month figure less the 6-month figure.Report this figure43.9Capital expenditure, Q4 FY2025, three months to 2025-12-31$43.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-06, accession 0000875045-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure51.2Capital expenditure, Q1 FY2026, three months to 2026-03-31$51.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure40.9Capital expenditure, Q2 FY2026, three months to 2026-06-30$40.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-29, accession 0000875045-26-000075. Derived: 6-month figure less the 3-month figure.Report this figure40.4Capital expenditure, Q3 FY2026, three months to 2026-09-30$40.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-28, accession 0000875045-26-000096. Derived: 9-month figure less the 6-month figure.Report this figure
Share repurchases$m0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-02-12, accession 0000875045-25-000009. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)147.80m, Q3 FY2026
Biogen Inc., shares, quarterly
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Diluted shares (weighted)m shares145Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31145,200,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-04-24, accession 0000875045-24-000016.Report this figure146Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30145,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-01, accession 0000875045-24-000025.Report this figure145Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30144,800,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-30, accession 0000875045-24-000032.Report this figure146Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31145,900,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-01, accession 0000875045-25-000018.Report this figure146Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30145,900,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-31, accession 0000875045-25-000033.Report this figure146Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30146,100,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-30, accession 0000875045-25-000049.Report this figure147Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31146,600,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure147Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30146,700,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure147Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30147,100,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure148Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31148,400,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-29, accession 0000875045-26-000045.Report this figure149Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30148,700,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-29, accession 0000875045-26-000075.Report this figure148Diluted shares (weighted), Q3 FY2026, three months to 2026-09-30147,800,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure

Shares outstanding: 147.82mShares outstanding, period not labelled, at 2026-10-26147,820,223 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-10-28, accession 0000875045-26-000096.Report this figure at Oct 26, 2026, from the cover of the 10-Q filed Oct 28, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 28, 2026, 07:28 ET. Listed shows no prices and gives no investment advice.